A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies
The purpose of this clinical research study is to learn about the safety and tolerability of daily BMS-275183 in patients with advanced cancer.
Tumors
DRUG: BMS-275183
Safety and Tolerability
PK, preliminary evidence of antitumor activity
The purpose of this clinical research study is to learn about the safety and tolerability of daily BMS-275183 in patients with advanced cancer.